Nasdaq

Haemonetics Says Supports FDA Guidance On Viscoelastic Testing During COVID-19 Pandemic

(RTTNews) - Haemonetics Corp. (HAE) said Friday it supports new guidance issued by the U.S. Food and Drug Administration or FDA related to the use of viscoelastic testing for the duration of the ...
Business Wire

FDA Grants HemoSonics 510(k) Clearance to Expand Use of Its Quantra Hemostasis System to Obstetric Procedures

The Quantra Hemostasis System provides comprehensive blood analysis that delivers rapid, real-time coagulation insights at the point of need, empowering clinicians with actionable data to make better ...
Nasdaq

Haemonetics' (HAE) New TEG 6s Cartridge Gets FDA Approval

Haemonetics Corporation HAE announced receipt of the FDA 510(k) clearance for the TEG 6s hemostasis analyzer system Global Hemostasis-HN assay cartridge. This new cartridge expands Haemonetics' TEG 6s ...
Becker's Hospital Review

Revolutionizing Bleeding Management

In this context, there have been significant advancements in hemostasis testing device technology. Leading surgical practices are now harnessing the power of next-generation viscoelastic testing (VET) ...